Jacob D. Cohen 13D and 13G filings for Mangoceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-27 7:45 pm Purchase |
2024-08-26 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 721,667 34.200% |
16,667 (+2.36%) |
Filing |
| 2024-06-05 5:15 pm Purchase |
2024-06-03 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 705,000 34.700% |
53,333 (+8.18%) |
Filing |
| 2023-12-29 9:51 pm Purchase |
2023-12-28 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 651,667 42.600% |
100,000 (+18.13%) |
Filing |
| 2023-05-02 8:55 pm Purchase |
2023-04-10 | 13D | Mangoceuticals, Inc. MGRX |
Jacob D. Cohen | 551,667 47.800% |
551,667 (New Position) |
Filing |